Relative effect of APOE ε4 on neuroimaging biomarker changes across the lifespan

Julie Gonneaud1, Eider M Arenaza-Urquijo2, Marine Fouquet2

  • 1From INSERM (J.G., E.M.A.-U., M.F., A.P., V.d.L.S., F.E., G.C.), U1077; Université de Caen Normandie, UMR-S1077 (J.G., E.M.A.-U., M.F., A.P., V.d.L.S., F.E., G.C.) and Ecole Pratique des Hautes Etudes, UMR-S1077 (J.G., E.M.A.-U., M.F., A.P., V.d.L.S., F.E., G.C.); and CHU de Caen, U1077 (J.G., E.M.A.-U., M.F., A.P., F.E., G.C.), Service de Biochimie (S.F.), and Service de Neurologie (V.d.L.S.), France. gonneaud@cyceron.fr.

Neurology
|September 30, 2016
PubMed
Abstract